Moderna Inc

Change company Symbol lookup

Select an option...

MRNA Moderna Inc

CVX Chevron Corp

ASCB ASPAC II Acquisition Corp

STRS Stratus Properties Inc

ESMC Escalon Medical Corp

ATO Atmos Energy Corp

LVS Las Vegas Sands Corp

HUBB Hubbell Inc

PM Philip Morris International Inc

TSP TuSimple Holdings Inc

Go

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) inched 0.15% higher to $118.25 Friday, on what proved to be an all-around poor trading session for the stock...(MarketWatch)

By Ciara Linnane U.K. is the only G-7 country with a smaller economy now than before the pandemic About half of the American public has heard little or nothing about the new COVID-19 bivalent booster, a new survey by the Kaiser Family...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) slid 3.34% to $118.07 Thursday, on what proved to be an all-around grim trading session for the stock market...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) sank 0.07% to $122.15 Wednesday, on what proved to be an all-around favorable trading session for the stock...(MarketWatch)

By Ciara Linnane Cases are rising again in northern Europe and almost half of U.S. states The Canadian government announced Monday it will no longer require people to wear masks on planes to guard against COVID-19, the Associated...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) rallied 2.12% to $122.23 Tuesday, on what proved to be an all-around mixed trading session for the stock...(MarketWatch)

By Ciara Linnane Moderna wants adolescents and younger children to be eligible for its bivalent vaccine Pfizer and German partner BioNTech said Monday they're seeking Food and Drug Administration authorization for their...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) slid 3.19% to $119.69 Monday, on what proved to be an all-around grim trading session for the stock market...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) dropped 0.55% to $123.64 Friday, on what proved to be an all-around dismal trading session for the stock...(MarketWatch)

Jaimy Lee Plus, Moderna is 'eager' to sell its COVID-19 shot in China, and U.S. cases continue to decline. A Food and Drug Administration official said this week that updated COVID-19 boosters for 5- to 11-year-olds will be authorized...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) slipped 1.15% to $124.32 Thursday, on what proved to be an all-around grim trading session for the stock...(MarketWatch)

Jaimy Lee Moderna still plans to deliver 70 million doses of its bivalent COVID-19 booster by the end of the year. Moderna Inc. (MRNA) said Wednesday that it expects to resolve supply issues for its new COVID-19 booster "in the coming...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) slipped 3.04% to $125.76 Wednesday, on what proved to be an all-around poor trading session for the stock...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) rallied 1.41% to $129.71 Tuesday, on what proved to be an all-around poor trading session for the stock market...(MarketWatch)

By Ciara Linnane Bus transporting people to quarantine crashes in China; Munich kicks off Oktoberfest Health experts reacted with dismay Monday to President Joe Biden's assertion that the pandemic is over in an interview on "60...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) slipped 7.14% to $127.90 Monday, on what proved to be an all-around favorable trading session for the stock...(MarketWatch)

By Vivien Lou Chen and William Watts U.S. stocks found their footing in the final hour of trading on Monday, after flipping between gains and losses, as investors prepared for a Federal Reserve meeting that's expected to deliver another...(MarketWatch)

Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with "60 Minutes" that aired on Sunday. Moderna Inc. fell 9.2%, Pfizer Inc. was down 1.7% and its German partner...(MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Moderna Inc. (MRNA) rose 1.38% to $137.74 Friday, on what proved to be an all-around grim trading session for the stock market...(MarketWatch)

By Ciara Linnane Novavax vaccine allowed for children in Israel and adolescents in Taiwan A flurry of regulatory announcements relating to COVID treatments, vaccines and boosters dominated headlines on the pandemic Friday, with Europe...(MarketWatch)